GlassScriptPhysician profile
David B Remley
NPI 1891805347
$2,074.23
in general payments reported to CMS, 2019-2025
24 companies · $532 in 2025
The $532 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $203 · 2021: $315 · 2022: $440 · 2023: $182 · 2024: $241 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.23 | 2019-2023 | |
| Organon LLC | $278.40 | 2021-2025 | Nexplanon, Jada System, Nuvaring |
| Medical Device Business Services, INC. | $149.03 | 2025 | Harmonic |
| Astellas Pharma US INC | $139.29 | 2023-2025 | Veozah |
| Baxter Healthcare | $124.97 | 2020 | |
| Davol INC. | $120.57 | 2022 | |
| Ethicon US, LLC | $97.12 | 2024-2025 | Dermabond, Ethicon |
| Mayne Pharma Commercial LLC | $86.91 | 2022-2025 | |
| Pfizer INC. | $82.98 | 2022-2025 | |
| Hologic Sales and Service, LLC | $75.87 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Zimmer Biomet Holdings, INC. | $67.99 | 2021 | |
| Shield Therapeutics INC | $65.16 | 2022-2025 | Accrufer |
| Daiichi Sankyo INC. | $34.92 | 2022 | |
| Inari Medical, INC. | $28.99 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Therapeuticsmd, INC. | $27.57 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.59 | 2019 | |
| Evofem Biosciences, INC. | $23.07 | 2021 | |
| Intuitive Surgical, INC. | $20.06 | 2021 | |
| Convatec INC. | $19.45 | 2025 | |
| Medtronic, INC. | $16.38 | 2022 | |
| Sage Therapeutics, LLC | $15.53 | 2024 | |
| Boston Scientific Corporation | $15.22 | 2021 | |
| Myovant Sciences INC. | $12.40 | 2021 | |
| Allergan, INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Remley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.